Cargando…
Peri‐operative hemostatic management of tooth extraction in patients with hemophilia A, with and without inhibitors, receiving emicizumab prophylaxis
INTRODUCTION: Emicizumab treatment may allow patients with hemophilia A without (PwHA) and with inhibitors (PwHA‐I) to undergo some minor surgeries, such as tooth extraction, without peri‐operative factor infusions. However, criteria for determining the necessity of factor infusions before minor sur...
Autores principales: | Yagyuu, Takahiro, Furukawa, Shoko, Zaizen, Miki, Yata, Sachiko, Imada, Mitsuhiko, Nogami, Keiji, Kirita, Tadaaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087157/ https://www.ncbi.nlm.nih.gov/pubmed/36163647 http://dx.doi.org/10.1111/hae.14667 |
Ejemplares similares
-
Two pediatric cases of severe hemophilia A in which emicizumab prophylaxis failed to prevent traumatic extra-articular hemorrhage
por: Yamada, Yuya, et al.
Publicado: (2022) -
Impact of beta-tricalcium phosphate on preventing tooth extraction-triggered bisphosphonate-related osteonecrosis of the jaw in rats
por: Funayama, Naoki, et al.
Publicado: (2023) -
Effect of smoking status and programmed death-ligand 1 expression on the microenvironment and malignant transformation of oral leukoplakia: A retrospective cohort study
por: Yagyuu, Takahiro, et al.
Publicado: (2021) -
Spotlight on emicizumab in the management of hemophilia A: patient selection and special considerations
por: Yada, Koji, et al.
Publicado: (2019) -
Serious bleeds in pediatric persons with hemophilia A on emicizumab prophylaxis
por: Garcia, Jessica, et al.
Publicado: (2023)